摘要
目的评价多糖铁胶囊治疗围生期缺铁性贫血的临床疗效。方法将218例围生期缺铁性贫血患者随机分为2组,其中治疗组112例给予多糖铁胶囊治疗,对照组106例给予硫酸亚铁治疗。4周后复查,观察2组临床疗效及不良反应。结果治疗组总有效率为100.0%高于对照组的75.5%,治疗组不良反应发生率为7.1%低于对照组的28.3%,差异均有统计学意义(P<0.05)。结论多糖铁胶囊治疗围生期缺铁性贫血安全、有效,不良反应小,应作为治疗缺铁性贫血孕产妇的首选药物。
Objective To evaluate the clinical effect of polysaccharide capsule in perinatal period iron deficiency anemia.Methods 218 cases patients with perinatal period iron deficiency anemia were randomly divided into treatment group(112 cases,were treated polyferose capsules) and control group(106 cases,were treated with ferrous sulfate).After 4 weeks,observed the clinical effect and adverse reaction.Results The total effective rate of treatment group(100.0%) was higher than that of control group(75.5%),the incidence of adverse reaction of treatment group(7.1%) was lower than that of control group(28.3%),the difference were statistically significant(P0.05).Conclusion Polysaccharide capsule in perinatal period iron deficiency anemia is safe,effective,adverse reaction less,should be the choice drug of treating iron deficiency anemia drug for pregnant women.
出处
《临床合理用药杂志》
2011年第17期22-23,共2页
Chinese Journal of Clinical Rational Drug Use
关键词
多糖铁胶囊
贫血
缺铁性
围生期
Polysaccharide capsule
Anemia
iron deficiency
Perinatal period